Events

Covidien LigaSure Exact Dissector Nano-Coated 20.6mm-21cm 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Medtronic Australasia Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2018-RN-00261-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2018-03-20
  • 사례 국가
    Australia
  • 사례 출처
    DHTGA
  • 사례 출처 URL
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2018-RN-00261-1
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    This recall is being conducted due to the potential for the sterile packaging to be compromised, as a result of holes in the sterile packaging. the use of products with this condition may result in a potentially increased risk for infection. there have been no reports of infection associated with this issue.
  • 조치
    Medtronic is advising users to inspect stock and quarantine any remaining units of the affected batches. Affected stock can be returned to Medtronic for credit.

Device

Covidien LigaSure Exact Dissector Nano-Coated 20.6mm-21cm
  • 모델명 / 제조번호(시리얼번호)
    Covidien LigaSure Exact Dissector Nano-Coated 20.6mm-21cm Item Code: LF2019Lot Numbers:72550127X, 72770140X, 72770141X, 73000048XShipped between November 2017 and February 2018ARTG number: 178655(Medtronic Australasia - Electrode, electrosurgical, active, hand-controlled, single use)
  • Manufacturer
    Medtronic Australasia Pty Ltd

Manufacturer

Medtronic Australasia Pty Ltd
  • 제조사 모회사 (2017)
    Medtronic plc
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    DHTGA